Market Cap
$12.71M
Shares Outstanding
7.0M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Dec 4, 2025
Round Lot
100
Locale
US
Day Open
$1.81
Day High
$1.85
Day Low
$1.74
Volume
28.9K
VWAP
$1.81
Prev Close
$1.81
Transactions
--
Acc. Volume
--
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Regentis Biomaterials Ltd. (RGNT) closed the 2026-09-16 session at $1.80, down 0.55% versus the previous close (-0.01). The stock opened at $1.81 and traded between $1.74 and $1.85 during that session. Session trading volume was 29K shares. The volume-weighted average price (VWAP) is $1.81.
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Regentis Biomaterials Ltd. has a market capitalization of $12.7 million. RGNT is listed on the XASE exchange. The company employs approximately 8 people. The recorded listing date is 2025-12-04.
On this page you can find market RGNT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.